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S U M M A R Y
The fungus Trichosporon asahii is distributed widely in the environment and is frequently isolated from
clinical specimens. It can cause life-threatening disseminated infections, including breakthrough
infection after the administration of candin antifungal drugs. However, the deﬁnitive infection route is
still unclear. In this study, 43 T. asahii genotypes were detected in 72 fecal samples from healthy subjects.
The rRNA genotypes of the species were determined using a culture-independent method. The
genotypes of T. asahii were almost identical to those of reported clinical isolates. Therefore, T. asahii
colonizing the gastrointestinal tract might be associated with the development of trichosporonosis, and
not environmental isolates.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Trichosporonosis, a deep-seated opportunistic fungal infection,
is caused by Trichosporon asahii.1 Since the ﬁrst case of human
infection due to Trichosporon was reported in a patient with a
brain abscess in 1970, the number of reported cases has increased
gradually. An estimated 5–10% of all deep-seated fungal infections
are trichosporonosis. Trichosporon infections appear to be more
common in patients with hematological malignancies who are on
cytotoxic chemotherapy resulting in neutropenia. The prognosis of
trichosporonosis is very poor; the mortality rate approaches 80%, a
rate higher than that for candidiasis.1 In the last decade,
breakthrough trichosporonosis infection after the administration
of echinocandin antifungal drugs has been problematic clinically.2
In addition to infection, T. asahii also causes summer-type
hypersensitivity pneumonitis (SHP), a type III or IV allergy that
occurs after inhaling arthroconidia of the causative microorgan-
isms. The microorganisms are often isolated from the patient’s gut,
suggesting that gastrointestinal colonization is one route of deep-
seated trichosporonosis infection. However, they also colonize
human skin and are distributed widely in the environment.1* Corresponding author. Tel.: +81 424 95 8762; fax: +81 424 95 8762.
E-mail address: sugita@my-pharm.ac.jp (T. Sugita).
http://dx.doi.org/10.1016/j.ijid.2015.09.009
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).In this study, rRNA genotyping using a culture-independent
method was performed and it was found that T. asahii is part of the
normal microbiota of the human gut.
Methods
This study obtained fecal samples from 72 healthy Japanese
subjects: 47 males (mean age 32.2  10.0 years) and 25 females
(mean age 31.5  10.4 years). Fungal DNA was extracted from the
fecal samples using a QIAamp DNA Stool Mini Kit (Qiagen, Tokyo,
Japan). The intergenic spacer 1 (IGS1) region, which is located
between the 5S and 26S subunits of the rRNA gene, was ampliﬁed
according to the method of Sugita et al.,3 and the amplicons were
cloned into TOPO vector (Invitrogen, Tokyo, Japan) for sequencing,
according to the manufacturer’s instructions.
Results
T. asahii IGS1 DNA was detected in 43 of the 72 samples (43/72,
59.7%). Other Trichosporon species were detected in four samples:
T. faecale in two cases and T. asteroids and T. ovoides in one case
each. Twelve genotypes have been identiﬁed in the IGS1 region of
T. asahii. Genotype 1 predominated in the 43 samples (36/43, 83.7%),ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Trichosporon asahii genotypes detected in human feces
Species Gut Skin
(%)6
Clinical
specimens
(%)3
Environmental
(%)9
T. asahii genotype 1 36 (83.7%) 78.8 86.7 5.6
T. asahii genotype 2 3.5 3.3
T. asahii genotype 3 6 (14.0%) 2.9 83.3
T. asahii genotype 4 1 (2.3%) 6.5 6.7 2.8
T. asahii genotype 5 2.4 3.3 8.3
T. asahii genotype 6 5.3
T. asahii genotype 7 0.6
T. asahii genotype 8
T. asahii genotype 9
T. asahii genotype 10
T. asahii genotype 11
T. asahii genotype 12
Trichosporon faecale 2
Trichosporon asteroides 1
Trichosporon ovoides 1
O. Cho et al. / International Journal of Infectious Diseases 39 (2015) 87–8888followed by genotype 3 (6/43, 14.0%); genotype 4 (1/43, 2.3%) was
detected in only one sample (Table 1 ).
Discussion
The internal transcribed spacer (ITS) and large subunit (LSU) of
the rRNA gene are used widely for fungal identiﬁcation, whereas
the IGS is used as a molecular epidemiological tool, as the region
exhibits remarkable intra-species diversity. The IGS is also used for
multilocus sequence typing analysis of Cryptococcus neoformans
and Cryptococcus gattii.4 The IGS1 sequence can also be used as a
molecular epidemiological tool for T. asahii.
In Japanese clinical isolates, genotype 1 of T. asahii predomi-
nates, whereas genotypes 3 and 5 predominate in the USA.3 Large
studies conducted in Japan (380 cases) and Brazil (1004 cases) have
suggested that Trichosporon species are part of the fungal
microbiota of healthy human skin.5,6 The Japanese study also
revealed that T. asahii genotype 1 predominated in skin samples. T.
asahii has been isolated from various body sites: the gut, oral
cavity, sputum, skin, catheter, and blood.
The predominant IGS1 sequence of clinical strains obtained
from patients conformed to that of the strains colonizing healthy
gut and skin, suggesting that T. asahii colonizing the gastrointesti-
nal tract or skin translocates into blood. Animal studies have also
suggested that the pathogen can disseminate from the gut to the
blood.7 It was recently reported that T. asahii colonizes the gut of
inhabitants of Amazonia and Polynesia; in that study an rRNAclone library method was used, although genotyping studies were
not performed.8
T. asahii is also distributed widely in the environment and
causes SHP. The genotype of environmental T. asahii isolates is
predominantly genotype 3.9 Therefore, the probability that
environmental strains are associated with deep-seated infections
is low.
In conclusion, T. asahii is part of the normal microbiota of the
human gut and the IGS1 genotype detected in feces matched that
of strains obtained from patients with deep-seated infections.
Consequently, T. asahii colonizing the gastrointestinal tract or skin
might be associated with the development of deep-seated
trichosporonosis, and not environmental isolates.
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